Last update 01 Nov 2024

DNA-directed DNA polymerase x Top II

Basic Info

Related Targets
DNA-directed DNA polymeraseTop II

Related

1
Drugs associated with DNA-directed DNA polymerase x Top II
Cytarabine/Daunorubicin
Target
DNA-directed DNA polymerase x Top II
Mechanism
DNA-directed DNA polymerase inhibitors [+2]
Active Org.
Celator Pharmaceuticals, Inc.Celator Pharmaceuticals, Inc. [+10]
Originator Org.
Jazz Pharmaceuticals Plc
Active Indication
Treatment related acute myeloid leukaemia [+17]
Inactive Indication
acute leukemia [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date03 Aug 2017
89
Clinical Trials associated with DNA-directed DNA polymerase x Top II
NCT05628623 / Not yet recruitingPhase 2IIT
Eradicating Measurable Residual Disease in Patients With Acute Myeloid Leukemia (AML) Prior to StEm Cell Transplantation (ERASE): A MyeloMATCH Treatment Trial
100 Clinical Results associated with DNA-directed DNA polymerase x Top II
Login to view more data
100 Translational Medicine associated with DNA-directed DNA polymerase x Top II
Login to view more data
0 Patents (Medical) associated with DNA-directed DNA polymerase x Top II
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free